Health and Quality of Life One Year After Discharge From the Intensive Care Unit (ICU)
NCT ID: NCT02671916
Last Updated: 2019-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
55 participants
OBSERVATIONAL
2015-01-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of an ICU-specific Questionnaire for Patient-reported Outcome Measures
NCT02767180
5 Years Quality of Life and Early Mobilization in ICU
NCT05527678
Patient Reported Symptoms the First Week After Intensive Care Unit Discharge and up to Hospital Discharge
NCT05266118
Health-related Quality of Life and Functional Impairments After Intensive Care Unit Discharge
NCT05111522
COVID-19 Follow up Intensive Care Studies
NCT04460170
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
all patients
questionnaire for patients with ICU stay at least 5 days or longer without interruption at the ICU
questionnaire
Investigation on all study patients, no Intervention, no groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
Investigation on all study patients, no Intervention, no groups
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Prof. Dr. med. Cristoph Haberthür
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. med. Cristoph Haberthür
Prof. Dr. med.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christoph Haberthür, MD
Role: PRINCIPAL_INVESTIGATOR
Klinik Hirslanden, Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik Hirslanden
Zurich, Canton of Zurich, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
QOL_2015_HIRS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.